Profil
Al Blunt worked as Vice President-Medical at Advaxis, Inc. from 2017 to 2018.
He holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from City College.
Ehemalige bekannte Positionen von Al Blunt
| Unternehmen | Position | Ende |
|---|---|---|
| AYALA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01.10.2018 |
Ausbildung von Al Blunt
| University of Pennsylvania | Doctorate Degree |
| City College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
